NCT06879171

Brief Summary

This study will be held to overcome the previous limitations related to bone loss after teeth extraction by taking advantages from both Autogenous tooth graft and Simvastatin which will offer a promising synergistic approach for reducing alveolar ridge resorption, enhance bone regeneration and ensuring implant site development for future implant placement. This combination will address the gap in knowledge and offering a novel approach in alveolar ridge preservation. The Autogenous tooth graft will provide a scaffold and growth factor source for bone regeneration while Simvastatin will promotes osteogensis and angiogensis at graft site. So The goal of the present trial aims to evaluate the first-time application of Autogenous tooth graft from extracted tooth combined with Simvastatin with a ratio 1:1(test group) versus Autogenous tooth graft alone (control group) at an extraction socket of non molar single rooted teeth for alveolar ridge preservation and implant site development prior to implant placement. The participants will be divided into two groups: Intervention Group will receive Autogenous tooth graft combine with Simvastatin with a ratio 1:1 Control Group will receive Autogenous tooth graft. with follow up period 4 months.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jun 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jun 2025Jun 2026

First Submitted

Initial submission to the registry

March 11, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 17, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

June 10, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2026

Expected
Last Updated

May 20, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

March 11, 2025

Last Update Submit

May 19, 2025

Conditions

Keywords

autogenous tooth graftsimvastatindelayed implantalveolar ridge preservation

Outcome Measures

Primary Outcomes (1)

  • Horizontal bone width

    Pre- and Post-ARP CBCT Scans immediately and 4 months after grafting The scans will be compared using predetermined reference points to assess the bone width changes.

    4 months after grafting

Secondary Outcomes (2)

  • vertical bone height

    4 months after grafting

  • percentage of newly formed bone

    4 months

Study Arms (2)

autogenous tooth graft combined with simvastatin 1:1

EXPERIMENTAL

Test group : autogenous tooth graft from the extracted tooth combined with simvastatin drug with a ratio 1:1

Procedure: Alveolar ridge preservation

Autogenous tooth graft

ACTIVE COMPARATOR

Control group : Autogenous tooth graft

Procedure: Alveolar ridge preservation

Interventions

Grafting of the socket with Autogenous tooth graft mixed with simvastatin immediately after tooth extraction

autogenous tooth graft combined with simvastatin 1:1

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with badly broken, non-restorable, or periodontally hopeless non molar single rooted teeth.
  • Age from 20-45 years old(6,13). No sex predilection.
  • Medically free from any medical condition that would interfere with bone healing.
  • Patients with status classification (ASA I \& II) with adequate oral hygiene condition.
  • Alveolar sockets free from any preexisting periapical pathology based on intraoral periapical or panoramic radiograph.

You may not qualify if:

  • Patients with any medical condition that contraindicated the procedure and general contraindications for Implant Surgery(6,13)
  • Patients who are allergic to Simvastatin drug.(6)
  • Presence of active infection around the tooth or remaining root.
  • Psychological reasons that might affect the procedure or the subsequent follow up visits.
  • Heavy smokers
  • Immunosuppressed or Immunocompromised.(13)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Janjua OS, Qureshi SM, Shaikh MS, Alnazzawi A, Rodriguez-Lozano FJ, Pecci-Lloret MP, Zafar MS. Autogenous Tooth Bone Grafts for Repair and Regeneration of Maxillofacial Defects: A Narrative Review. Int J Environ Res Public Health. 2022 Mar 20;19(6):3690. doi: 10.3390/ijerph19063690.

    PMID: 35329377BACKGROUND
  • Beca-Campoy T, Sanchez-Labrador L, Blanco-Antona LA, Cortes-Breton Brinkmann J, Martinez-Gonzalez JM. Alveolar ridge preservation with autogenous tooth graft: A histomorphometric analysis of 36 consecutive procedures. Ann Anat. 2025 Feb;258:152375. doi: 10.1016/j.aanat.2025.152375. Epub 2025 Jan 6.

    PMID: 39778754BACKGROUND
  • Zhang S, Li X, Qi Y, Ma X, Qiao S, Cai H, Zhao BC, Jiang HB, Lee ES. Comparison of Autogenous Tooth Materials and Other Bone Grafts. Tissue Eng Regen Med. 2021 Jun;18(3):327-341. doi: 10.1007/s13770-021-00333-4. Epub 2021 Apr 30.

    PMID: 33929713BACKGROUND

Related Links

Study Officials

  • Nadia Galal professor, phd holder

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nourhan Mohamed Abd Elwahab, Bachelor of Dental Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study participants will be blinded and each patient will be given a code by the researcher (N.M). Blinding of the investigator (N.M) isn't applicable. Biostatistician will be blinded. Participants' identity and their corresponding study group will be concealed by assigning an identification number to all laboratory specimens, data files and reports for the transfer data to and from assessors.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial (RCT) with parallel group ,two arms, with 1:1 allocation ratio.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dentist

Study Record Dates

First Submitted

March 11, 2025

First Posted

March 17, 2025

Study Start

June 10, 2025

Primary Completion

December 10, 2025

Study Completion (Estimated)

June 10, 2026

Last Updated

May 20, 2025

Record last verified: 2025-03